Ticker Details
Terns Pharmaceuticals, Inc.
IPO Date:	February 1, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$5.44B
Activated in VL:	False

Average Daily Range
Avg Daily Range:	$0.38 | 4.06%
Avg Daily Range (30 D):	$0.94 | 2.22%
Avg Daily Range (90 D):	$1.14 | 3.25%

Institutional Daily Volume
Avg Daily Volume:	.75M
Avg Daily Volume (30 D):	1.85M
Avg Daily Volume (90 D):	2.59M

Trade Size
Avg Trade Size (Sh.):	99
Avg Trade Size (Sh.) (30 D):	69
Avg Trade Size (Sh.) (90 D):	78

Institutional Trades
Total Institutional Trades:	1,791
Avg Institutional Trade:	$2.79M
Avg Institutional Trade (30 D):	$3.16M
Avg Institutional Trade (90 D):	$3.31M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$3.78M
Avg Closing Trade (30 D):	$11.22M
Avg Closing Trade (90 D):	$9.9M
Avg Closing Volume:	215.01K

News

Apr 7, 2026 @ 6:28 PM Merck Lowered Terns Pharmaceuticals Offer Price Af... Source: Vandana Singh

Apr 7, 2026 @ 4:46 PM What's Going On With Merck Stock Tuesday? Source: Nabaparna Bhattacharya

Apr 2, 2026 @ 3:32 PM Merck Just Made a Big Bet on a New Cancer Growth E... Source: Jessica Mitacek

Apr 1, 2026 @ 1:26 PM Merck Locks Infinimmune Alliance To Chase Next-Gen... Source: Vandana Singh

Mar 25, 2026 @ 3:20 PM Merck's $6.7 Billion Terns Pharmaceuticals Acquisi... Source: Vandana Singh

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.03	$-.24	$-1.03
Diluted EPS	$-1.03	$-.24	$-1.03
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-96.21M	$-23.57M	$-96.21M
Operating Income / Loss	$-110.12M	$-27.6M	$-110.12M
Cost of Revenue
Net Cash Flow	$363.31M	$374.05M	$363.31M
PE Ratio